Previous 10 | Next 10 |
home / stock / seovf / seovf news
(TheNewswire) Sernova’s Cell Pouch platform and cell therapy expertise being used in multiple collaborations with global pharmaceutical companies LONDON, ONTARIO – TheNewswire - January 28, 2021 – Sernova Corp. (TSXV...
(TheNewswire) LONDON, ONTARIO – TheNewswire - January 25, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company is pleased to announce that in recent weeks it has received gros...
(TheNewswire) LONDON, ONTARIO – TheNewswire - January 21, 2021 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company announced today that Dr. Philip Toleikis, President and CEO has been invited to parti...
Sernova ([[SEOVF]] +61.9%) announces that its principal clinical investigator, presented additional positive preliminary safety and efficacy data for its diabetes Cell Pouch at the 2021 American Society of Transplant Surgeons Winter Symposium.Sernova’s Cell Pouch transplante...
(TheNewswire) Sernova’s Cell Pouch System shows sustained clinical benefit in study patients with type 1 diabetes through multiple efficacy indicators and ongoing safety and tolerability LONDON, ONTARIO – TheNewswire - January 15, 2021 &...
(TheNewswire) December 18, 2020 - 9:00 a.m. EST LONDON, ONTARIO - TheNewswire – December 18, 2020 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, today announces that Dr....
(TheNewswire) London, Ontario - TheNewswire – December 16, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) continues to gain attention this week as the company shares have reached new levels over the past few days. Dr. Philip Toleikis, President an...
(TheNewswire) LONDON, ONTARIO – TheNewswire - December 11, 2020 – At the request of IIROC (“Investment Industry Regulatory Organization of Canada”), Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SV...
(TheNewswire) London, Ontario - TheNewswire - December 3 , 2020 - Interest in Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) is growing rapidly. With its medical advances and latest announcements, Sernova has garnered attention in the fields of regenerati...
(TheNewswire) LONDON, ONTARIO - TheNewswire - November 30, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF ) (FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce that Dr. Piotr Witkowski, principal investigator...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – TheNewswire - July 15, 2024 – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatment o...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...